Financials
Income statement
| Fiscal date | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|
| Total reported revenue | 5.5B | — | 4.2B | — |
| Cost of revenue | 1.3B | — | 881M | — |
| Gross profit | 4.2B | — | 3.3B | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 57M | — | 27M | — |
| Other operating expenses | 269M | — | 211M | — |
| Operating income | 3.6B | — | 2.4B | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 25M | — | 3.0B | — |
| Other income expense | — | — | — | — |
| Pretax income | 4.9B | — | 3.6B | — |
| Tax provision | 781M | — | 411M | — |
| Net income | 4.1B | — | 3.2B | — |
| Basic EPS | 3.2 | 2.5 | — | 2.4 |
| Diluted EPS | 3.2 | 2.5 | — | 2.3 |
| Basic average shares | 9.9B | 9.9B | — | 9.8B |
| Diluted average shares | 9.9B | 9.9B | — | 9.9B |
| EBITDA | 3.9B | — | 8.2B | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | -21M | — | -30M | — |
| Preferred stock dividends | 0 | — | 0 | — |